What SoftWave Therapy Is and How It Works
SoftWave is a brand of technology that delivers unfocused extracorporeal shock waves — acoustic pulses generated outside the body and transmitted through the skin into the underlying tissue. “Extracorporeal” means the energy source remains external; the waves travel into the body rather than being inserted into it.
The therapeutic mechanism works on several levels. At the cellular level, acoustic waves create a phenomenon called cavitation — the rapid formation and collapse of microscopic bubbles in fluid — which produces mechanical stress that triggers biological responses in the surrounding tissue. Those responses include increased local blood flow, the recruitment of stem cells to the treatment site, and the release of growth factors that promote repair. At the tissue level, shock wave therapy has been shown to stimulate collagen production, reduce calcific deposits in tendons, and interrupt the cycle of chronic inflammation that prevents some injuries from healing.
This is meaningfully different from treatments that mask pain by suppressing the inflammatory response. SoftWave does not deliver a drug or a cellular concentrate — it delivers a physical stimulus that prompts the tissue to begin doing what it would do after a fresh injury: recruit repair resources and rebuild. For patients whose injuries have become chronic and stalled, that biological reset is the point.
At ReNova Health, we offer SoftWave as part of our non-invasive pain management options. Because it requires no anesthesia, no needles, and no downtime, it is often a practical starting point for patients who are not yet ready for injection-based regenerative treatments or who want to explore options that don’t involve any kind of puncture.
Conditions We Use SoftWave to Treat
The clinical evidence base for extracorporeal shock wave therapy covers a wide range of musculoskeletal conditions. We evaluate SoftWave candidacy for patients presenting with plantar fasciitis, Achilles tendinopathy, patellar tendinopathy, lateral epicondylitis (tennis elbow), rotator cuff tendinopathy, calcific tendinitis of the shoulder, and chronic soft tissue injuries that have not resolved with physical therapy or rest.
The review literature is particularly robust for tendinopathies — conditions involving chronic degeneration of tendon tissue rather than acute tears — where conventional conservative treatment has a ceiling. Tendons have limited blood supply, which restricts their natural healing capacity. Shock wave therapy addresses this directly by stimulating local vascular response and cellular activity that the tendon cannot generate on its own.
SoftWave is not appropriate for all presentations. Active infection, open wounds, certain circulatory conditions, and pregnancy at or near the treatment site are standard contraindications. We review each patient’s history before treatment to confirm it’s appropriate for their specific situation.
What a SoftWave Session Involves
SoftWave treatment is delivered by a handheld device applied to the skin surface over the target tissue. A coupling gel — similar to what’s used in ultrasound imaging — is applied first to ensure efficient transmission of the acoustic energy. The device is moved across the treatment area in a systematic pattern while delivering pulses at a calibrated intensity.
Sessions typically run between 10 and 20 minutes depending on the size and number of areas being treated. Most patients tolerate the procedure well; the sensation is often described as a series of firm pulses or thumps against the skin. Some patients experience mild discomfort over calcified areas or particularly inflamed tissue, which usually subsides within the session or shortly after.
There is no sedation, no recovery period, and no activity restriction following treatment. Most patients return to their normal routine immediately. A series of sessions is typically recommended — the number depends on the condition and how the tissue is responding — and we reassess at each visit rather than committing to a fixed protocol before we know how you’re responding.
Addressing Common Concerns About Non-Invasive Treatments
Two questions come up reliably when patients are considering SoftWave: whether a treatment with no injection or incision can actually do anything meaningful, and whether it’s worth the cost when insurance coverage is limited.
On efficacy: the mechanisms behind acoustic wave therapy are well-documented in peer-reviewed literature, and the evidence base for tendinopathy applications in particular has accumulated over more than two decades of clinical use. The absence of a needle doesn’t indicate a lack of biological effect — the energy delivered to the tissue is real, measurable, and has demonstrated physiological consequences. That said, results vary by individual and by condition, and we don’t make outcome guarantees. What we do is match treatment to the patient profile where the evidence is strongest.
On cost: SoftWave is not covered by most insurance plans. We discuss cost before any commitment is made. For many patients, the relevant comparison is SoftWave against continued physical therapy with diminishing returns, repeated cortisone cycles, or the out-of-pocket and recovery burden of a more invasive procedure. We help patients think through that comparison based on their specific situation, not a generic script.
Frequently Asked Questions
How many sessions will I need? Most treatment protocols involve between three and six sessions, spaced one to two weeks apart. Some patients notice changes after the first or second session; for others the response develops more gradually. We evaluate how you’re responding at each visit and adjust accordingly rather than locking in a fixed number upfront.
Can SoftWave be combined with other treatments? Yes, in many cases. SoftWave is often used alongside PRP therapy or as a standalone option for patients who are not candidates for injection-based treatments. We discuss combination approaches during the consultation when they’re clinically appropriate.
Is SoftWave the same as ultrasound therapy? No. Diagnostic ultrasound uses sound waves to produce images. Therapeutic ultrasound delivers low-intensity sound energy to warm tissue. SoftWave delivers high-energy acoustic pulses — a fundamentally different mechanism operating at a different intensity and with different biological effects. They are not interchangeable.
Will it hurt? Most patients describe the sensation as firm pressure or a thumping feeling. Discomfort varies depending on the treated area and the degree of inflammation present. We calibrate intensity based on your tolerance during the session and can adjust in real time.
What if I’ve already tried shockwave therapy elsewhere and it didn’t work? Device type, protocol, and application technique vary considerably between providers. SoftWave uses unfocused shock wave technology, which differs from focused devices used in some clinical settings. If you’ve had shockwave treatment previously without meaningful results, it’s worth discussing the specifics — the device and protocol used — so we can assess whether a different approach is likely to produce a different outcome.
Key Takeaways
- SoftWave therapy uses acoustic waves delivered externally to stimulate the body’s repair processes — no needles, no incisions, no anesthesia, no downtime.
- The mechanism involves cavitation, increased local blood flow, stem cell recruitment, and growth factor release — a biological stimulus, not a symptom suppressant.
- Published review evidence supports extracorporeal shock wave therapy across a broad range of musculoskeletal conditions, particularly tendinopathies where conventional conservative care has not produced lasting results.
- Treatment involves a series of sessions; most patients tolerate it well with no recovery period required.
- Insurance coverage is limited. Results vary by individual. Candidacy is reviewed before treatment begins.
If you’re dealing with a tendon injury, chronic soft tissue pain, or a musculoskeletal condition that hasn’t responded to conservative care, SoftWave may offer a non-invasive path forward. Contact ReNova Health to schedule a consultation and find out whether it’s a fit for your specific condition.
References
National Institutes of Health. Extracorporeal Shock Wave Therapy for the Treatment of Musculoskeletal Pain: A Narrative Review. https://pmc.ncbi.nlm.nih.gov/articles/PMC10648068/
Medical Disclaimer
The information in this blog is provided for educational purposes only and does not constitute medical advice. SoftWave therapy and other regenerative treatments should only be pursued under the guidance of a licensed healthcare provider with full knowledge of your medical history. Individual results vary. Not all patients are candidates — a clinical evaluation is required before any treatment is recommended or performed. Please consult a qualified provider to discuss your specific condition and options.